Paroxysmal Supraventricular Tachycardia : Pathophysiology, Diagnosis, and Management - 31/07/16
, Kathy S. Magdic, RN, ACNP-BC, DNPRésumé |
Paroxysmal supraventricular tachycardia (PSVT) is a well-known and thoroughly studied clinical syndrome, characterized by regular tachycardia rhythm with sudden onset and abrupt termination. Most patients present with palpitations and dizziness, and their electrocardiogram demonstrates a narrow QRS complex and regular tachycardia with hidden or inverted P waves. PSVT is caused by re-entry due to the presence of inhomogeneous, accessory, or concealed conducting pathways. Hemodynamically stable patients are treated by vagal maneuvers, intravenous adenosine, diltiazem, or verapamil, hemodynamically unstable patients are treated by cardioversion. Patients with symptomatic and recurrent PSVT can be treated with long-term drug treatment or catheter ablation.
Le texte complet de cet article est disponible en PDF.Keywords : Paroxysmal supraventricular tachycardia, Wolff-Parkinson-White syndrome, Supraventricular arrhythmia, Accessory pathways
Plan
| Disclosure Statement: The authors have nothing to disclose. |
Vol 28 - N° 3
P. 309-316 - septembre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
